Carl Doyle

977 total citations
17 papers, 756 citations indexed

About

Carl Doyle is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Carl Doyle has authored 17 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Virology and 7 papers in Molecular Biology. Recurrent topics in Carl Doyle's work include HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (5 papers). Carl Doyle is often cited by papers focused on HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (5 papers). Carl Doyle collaborates with scholars based in United Kingdom, Canada and Netherlands. Carl Doyle's co-authors include Thomas Lehner, Lesley A. Bergmeier, Elaine Mitchell, Louisa Tao, Yufei Wang, Ian M. Jones, Roger H. Brookes, Nicola Cook, Mike Dennis and Graham Hall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Carl Doyle

17 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Doyle United Kingdom 14 441 396 236 219 82 17 756
Timothy M. Hanley United States 9 151 0.3× 549 1.4× 204 0.9× 87 0.4× 97 1.2× 17 852
Adel Benlahrech United Kingdom 13 199 0.5× 436 1.1× 140 0.6× 128 0.6× 94 1.1× 34 650
Jean Marc Jacqué United States 9 604 1.4× 442 1.1× 247 1.0× 179 0.8× 256 3.1× 9 889
Shar L. Waldrop United States 9 146 0.3× 438 1.1× 140 0.6× 277 1.3× 64 0.8× 11 693
Núria Gonzàlez Spain 17 328 0.7× 258 0.7× 204 0.9× 85 0.4× 168 2.0× 28 664
Manoj Kumar Tripathy France 12 313 0.7× 194 0.5× 184 0.8× 228 1.0× 208 2.5× 20 663
Valérie Monceaux France 20 816 1.9× 687 1.7× 163 0.7× 274 1.3× 274 3.3× 34 1.1k
Cécile Schiffer France 8 199 0.5× 349 0.9× 120 0.5× 53 0.2× 58 0.7× 8 486
Alexandra Duverger United States 13 276 0.6× 240 0.6× 193 0.8× 94 0.4× 214 2.6× 25 525
Rose Parkinson United States 13 182 0.4× 461 1.2× 203 0.9× 142 0.6× 82 1.0× 34 815

Countries citing papers authored by Carl Doyle

Since Specialization
Citations

This map shows the geographic impact of Carl Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Doyle more than expected).

Fields of papers citing papers by Carl Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Doyle. The network helps show where Carl Doyle may publish in the future.

Co-authorship network of co-authors of Carl Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Doyle. A scholar is included among the top collaborators of Carl Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Doyle. Carl Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hardman, Clare S., Yi‐Ling Chen, Marcin Wegrecki, et al.. (2022). CD1a promotes systemic manifestations of skin inflammation. Nature Communications. 13(1). 7535–7535. 11 indexed citations
2.
Shah, Mittal, Carl Doyle, Kevin Greenslade, et al.. (2021). Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis. Journal of Orthopaedic Translation. 29. 134–142. 14 indexed citations
3.
Gupta, Deepti, Frederick W. Muskett, Philip S. Renshaw, et al.. (2018). Structural and functional analysis of Dickkopf 4 (Dkk4): New insights into Dkk evolution and regulation of Wnt signaling by Dkk and Kremen proteins. Journal of Biological Chemistry. 293(31). 12149–12166. 23 indexed citations
4.
Burak, M. Furkan, Karen Inouye, Alexandra Lee, et al.. (2015). Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes. Science Translational Medicine. 7(319). 319ra205–319ra205. 73 indexed citations
5.
Holdsworth, Gill, Patrick M. Slocombe, Carl Doyle, et al.. (2012). Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors. Journal of Biological Chemistry. 287(32). 26464–26477. 78 indexed citations
6.
Meier, Christoph, T.A. Ceska, Carl Doyle, et al.. (2012). Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting. Journal of Structural Biology. 177(2). 329–334. 18 indexed citations
7.
Underwood, Jenny, et al.. (2002). Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women. Clinical & Experimental Immunology. 129(3). 493–501. 31 indexed citations
8.
Lehner, Thomas, Carl Doyle, Yufei Wang, et al.. (2001). Immunogenicity of the Extracellular Domains of C-C Chemokine Receptor 5 and the In Vitro Effects on Simian Immunodeficiency Virus or HIV Infectivity. The Journal of Immunology. 166(12). 7446–7455. 23 indexed citations
9.
Lehner, T, Martin Cranage, Louisa Tao, et al.. (2000). Up‐regulation of β‐chemokines and down‐modulation of CCR5 co‐receptors inhibit simian immunodeficiency virus transmission in non‐human primates. Immunology. 99(4). 569–577. 41 indexed citations
10.
Lehner, Thomas, Yufei Wang, Carl Doyle, et al.. (1999). Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. European Journal of Immunology. 29(8). 2427–2435. 32 indexed citations
11.
Lehner, Thomas, Lesley A. Bergmeier, Elaine Mitchell, et al.. (1999). The Effect of Route of Immunization on Mucosal Immunity and Protection. The Journal of Infectious Diseases. 179(s3). S489–S492. 37 indexed citations
12.
Lehner, Thomas, Yufei Wang, Carl Doyle, et al.. (1999). Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. European Journal of Immunology. 29(8). 2427–2435. 1 indexed citations
13.
Wang, Yufei, Louisa Tao, Elaine Mitchell, et al.. (1998). Generation of CD8 suppressor factor and β chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proceedings of the National Academy of Sciences. 95(9). 5223–5228. 56 indexed citations
14.
Mitchell, Elaine, Lesley A. Bergmeier, Carl Doyle, et al.. (1998). Homing of mononuclear cells from iliac lymphnodes to the genital and rectal mucosa in non-human primates. European Journal of Immunology. 28(10). 3066–3074. 35 indexed citations
15.
Lehner, Thomas, Yufei Wang, Martin Cranage, et al.. (1996). Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Medicine. 2(7). 767–775. 254 indexed citations
16.
Hanke, Thomas, D. F. Young, Carl Doyle, Ian M. Jones, & Richard E. Randall. (1995). Attachment of an oligopeptide epitope to the C-terminus of recombinant SIV gp160 facilitates the construction of SMAA complexes while preserving CD4 binding. Journal of Virological Methods. 53(1). 149–156. 7 indexed citations
17.
Doyle, Carl, et al.. (1995). Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. Journal of Virology. 69(2). 1256–1260. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026